Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
05/2008
05/14/2008EP1250455B1 Antisense inhibition of ptp1b expression
05/14/2008EP0892808B1 Detection probes, kits and assays
05/14/2008EP0772437B9 Compositions for delivery of genetic material
05/14/2008EP0755402B1 Alpha(1,3) galactosyltransferase negative swine
05/14/2008CN101180307A Ionic liquid supported synthesis
05/14/2008CN101180066A New uses of dinucleotide polyphosphate derivatives
05/14/2008CN101177663A DNA separating micro-fluidic chip
05/14/2008CN100387717C Methods for increasing plant cell proliferation by functionally inhibiting plant cyclin inhibitor gene
05/13/2008US7371928 Plant seed-specific expression promoter derived from sesame and seed-specific expression vector comprising the promoter
05/13/2008US7371927 Methods for modulating plant growth and biomass
05/13/2008US7371852 Alkyl-linked nucleotide compositions
05/13/2008US7371851 Hybridizing and ligating double stranded nucleic acids; identifying binary codes using labeled probes; does not require use of restriction enzymes
05/13/2008US7371850 Method and composition for reducing expression of ROCK-II
05/13/2008US7371849 Methods of constructing camel antibody libraries
05/13/2008US7371848 Chimeric promoters comprising a caulimovirus promoter enhancer for use in plants
05/13/2008US7371847 Yeast-origin promoter and vector and expression system using the same
05/13/2008US7371846 Chemokine coreceptor fusion for use prevention and treatment of viral infection; immunotherapy
05/13/2008US7371845 MAGE-A3 peptides presented by HLA class II molecules
05/13/2008US7371844 Polypeptide of given sequence which binds to receptors; gene expression; use in treatment of osteoporosis, bone loss and raising cyclic AMP levels in cells
05/13/2008US7371843 Cultured Xenopus laevis cell lines expressing mutant Adenomatous polyposis coli gene
05/13/2008US7371842 Polynucleotide encoding a 35 KDA protein thats binds to WF00144
05/13/2008US7371841 Identifying modulator of cold sensation and pain; drug screening; cancer diagnosis
05/13/2008US7371840 Isolation and characterization of ECA1, a gene overexpressed in endometrioid carcinomas of ovary and endometrium
05/13/2008US7371839 having high specific activity and strong oxidant resistance, and having excellent detergency that is to be added to a detergent
05/13/2008US7371838 expression cassette encoding a beta 1,4-N-acetylglucosaminyl (GalNAc) transferase polypeptide; campylobacter jejuni (C. jejuni); host cells; enzyme involved in synthesis of lipooligosaccharides including gangliosides and ganglioside mimics
05/13/2008US7371837 Human virus causing respiratory tract infection and uses thereof
05/13/2008US7371836 PRO526 nucleic acids
05/13/2008US7371835 p53-dependent apoptosis-inducing protein and method of screening for apoptosis regulator
05/13/2008US7371834 Apoptosis-inducing factor
05/13/2008US7371833 Nucleic acid molecules with specific recognition of native PrPSc, production and use
05/13/2008US7371832 Polynucleotides encoding molecules associated with cell proliferation
05/13/2008US7371830 Coated with pore-free outer glass layer comprised of boron oxide; core includes magnetite (Fe3O4) and Fe2O3; isolating nucleic acids by binding to surface
05/13/2008US7371828 Extracellular signal-regulated kinase sequences and methods of production and use
05/13/2008US7371827 Antibodies against the PRO1126 polypeptide
05/13/2008US7371824 PRO6093 polypeptides
05/13/2008US7371822 Polypeptide of given sequence; use in prevention and treatment of cardiovascular, metabolic, inflammatory disorders;
05/13/2008US7371817 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes by contacting blood with pro-polypeptides; cancer diagnosis
05/13/2008US7371815 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
05/13/2008US7371811 Polypeptide of given sequence; diagnosis and treatment of bipolar disorders
05/13/2008US7371735 Inhibitor oligonucleotides and their use for specific repression of a gene
05/13/2008US7371734 Oligonucleotide compositions and their use for the modulation of immune responses
05/13/2008US7371723 Therapeutic agents comprising pro-apoptotic proteins
05/13/2008US7371585 Membranes incorporating recognition moieties
05/13/2008US7371571 Recombinant mycobacteria overexpressing D-alanine ligase gene and uses therefore
05/13/2008US7371568 Centromere, telomere and recognition sequences for recombinase; fragment comprising antibody gene; site-directed recombination detected by green fluorescent protein
05/13/2008US7371560 Chlamydomonas with mutation of Moc1 gene which eliminates activity of mitochondrial transcription factor; oxidative phosphorylation using hydrogenase
05/13/2008US7371559 Polynucleotide of given sequence; treatment of chronic pain, migraine, asthma, urge incontinence, psoriasis, and cancer
05/13/2008US7371558 Genetically modified eschrichia strain which is capable of biocoversion a single cacrbon source into 1, 3 propanediol using fermentation; bioreactors
05/13/2008US7371555 Polypeptides having α-H-α-amino acid amide racemase activity and nucleic acids encoding the same
05/13/2008US7371554 Lachrymatory-factor synthase for use in identifying medicants for dry eye; producing onions with reduced lachrymatory factor and eye stinging
05/13/2008US7371553 Chemically modified enzymes with multiple charged variants
05/13/2008US7371552 Polypeptide
05/13/2008US7371551 Feedback-resistant homoserine transsuccinylases
05/13/2008US7371550 Protein of given sequence; improved action and substrate specificity; use in diagnosis kits
05/13/2008US7371549 Aldolase, and method for producing optically active IHOG and monatin
05/13/2008US7371548 Expression vector comprising nucleotide sequences coding enzymatic polypeptide associated with polyketide biosynthesis for use in identifying modulators of immune response and cell proliferative disorders and which prevent propagation of insects, fungi and parasites
05/13/2008US7371547 Fermentation using mutant Sinorhizobium with plasmid expressing a recombinant pyridoxol 5'-phosphate synthase polypeptide; glycine resistance; increased productivity
05/13/2008US7371546 Heat stable and saccharide specific hydrolase for use in producing glucose from starch
05/13/2008US7371540 Encodes a protein that interacts with human CD33, the DNA being highly homologous to a portion of the human dystrophin gene. screening for leukemic cells and associated disease states; gene therapy
05/13/2008US7371533 Attaching polypeptide to ends of DNA or RNA to generate doubly end-labeled polymers; free solution electrophoresis
05/13/2008US7371532 Immobilized on cantilever comprising piezoelectric element, measuring vibration frequency before and after cleavage; strontium bismuth tantalate, lead zirconate titanate
05/13/2008US7371531 Detection without amplification and interference; measuring efficacy; packaged array can be used in robotic assembly for automated analysis
05/13/2008US7371526 Reacting nucleic acids with magnesium/sodium bisulfite in presence of polyamine catalyst (guanidine) to create point mutations; kits
05/13/2008US7371524 Substituted azaporphyrins as fluorescence labels
05/13/2008US7371523 Phenylethanolamine-N-methyltransferase sequence variants
05/13/2008US7371520 Methods and apparati using single polymer analysis
05/13/2008US7371516 Methods for determining the specificity and sensitivity of oligonucleo tides for hybridization
05/13/2008US7371380 Anti-Cark antibodies and uses therefor
05/13/2008US7371207 Estrogen receptor α regulated gene expression, related assays and therapeutics
05/13/2008CA2370535C Replica amplification of nucleic acid arrays
05/13/2008CA1341573C Recombinant gamma interferons having enhanced stability and methods therefor
05/10/2008CA2610134A1 In vitro process for diagnosis of disease risks
05/08/2008WO2008054540A2 Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions
05/08/2008WO2008052335A1 Methods of determining risk and severity of disease in pigs
05/08/2008WO2008027452A3 Self-assembling oligonucleotides and methods
05/08/2008WO2007142792A3 Potent inhibition of influenza virus by specifically designed short interfering rna
05/08/2008WO2007136758A9 Sirna inhibition of p13k p85, p110, and akt2 and methods of use
05/08/2008WO2006076691A8 Irta-2 antibodies and their uses
05/08/2008WO2004092191A8 Polymeric oligonucleotide prodrugs
05/08/2008US20080109925 Transcriptional Regulatory Nucleic Acids, Polypeptides and Methods of Use Thereof
05/08/2008US20080109921 Expression vector comperising nucleotide sequences coding ADP glucose pyrophosphorylase (AGP) and soluble starch synthase (SSS) genes for use in transformation and propagation of plants with enhanced resistance to heat stress
05/08/2008US20080109920 Abiotic stress tolerance conferred by j-domain containing proteins
05/08/2008US20080109918 Materials and methods for tissue-specific targeting of ethylene insensitivity in transgenic plants
05/08/2008US20080109654 System and method for RFID transfer of MAC, keys
05/08/2008US20080108804 Using RNA templates to generate CDNA sequences; DNA sequencing
05/08/2008US20080108803 Functional and hyperfunctional siRNA directed against Bcl-2
05/08/2008US20080108802 Functional and hyperfunctional siRNA directed against Bcl-2
05/08/2008US20080108801 Conjugated lipophilic group with a modified nucleotide is used to target disease gene, cells, tissue, for drug delivery to entrance into tumor cells; ribose sugar of nucleotide is replaced with a cyclic carrier which has at least one attached phosphate or phosphorothioate group; antitumor biodrugs
05/08/2008US20080108797 Modified Human Growth Hormone Polypeptides and Their Uses
05/08/2008US20080108791 Modified Human Interferon Polypeptides and Their Uses
05/08/2008US20080108712 diagnosing and/or treating patients that either have or are at risk for developing cardiovascular disorders; diabetic patient or on hormone replacement therapy; biodrugs; determining the identity of the nucleotide at position -54,642 of a nucleotide sequence; microarrays
05/08/2008US20080108584 dsRNA with a sense strand containing a first sequence, an antisense strand containing a second sequence, comprises a nucleotide sequence which is substantially complementary to mRNA encoding IKK-B, upon contact with a cell expressing IKK-B, Inhibits IKK-B gene expression; antiinflammatory agent
05/08/2008US20080108582 Methods And Compositions For Combinatorial Approaches To Cancer Gene Therapy
05/08/2008US20080108565 An immunoglobulin heavy chain variable region, an immunoglobulin light chain variable region, together define a single binding site for binding human HGF; neutralizing the activity of HGF
05/08/2008US20080108561 DNA molecule corresponding to a nucleotide sequence of a cereal pollen major allergen; therapy of pollen-allergy diseases
05/08/2008US20080108560 Heterologous G-Csf Fusion Proteins
05/08/2008US20080108552 Beta 1-integrin inhibitory peptide modified by biotin, cystein, or carboxyfluorescein (FAM)
05/08/2008US20080108547 Protease Inhibitor
05/08/2008US20080108516 Synthesis of chemical tags
05/08/2008US20080108507 Method for in vitro molecular evolution of protein function